AI in brain cancer prediction is revolutionizing how we approach the diagnosis and management of pediatric gliomas, particularly in anticipating cancer relapse.A recent Harvard study demonstrated the superiority of AI tools in evaluating multiple magnetic resonance imaging (MRI) scans over time, providing more accurate predictions of relapse risk compared to traditional methods.